Our deep learning solutions are ideal for application to drug discovery, where the available data are particularly sparse and noisy. Alchemite™ can learn simultaneously across all experimental endpoints to target high-quality compounds and prioritise experimental resources. Our technology can be applied to projects in both small molecule and biologics.
In collaboration with Optibrium, our exclusive partners in small molecule drug discovery, Alchemite™ has been demonstrated to make more effective use of limited data than conventional QSAR, and confidently highlight the most www.optibrium.com/augmentedchemistry.predictions on which to base your decisions. For more information on small molecule drug discovery applications, please visit
Swipe to navigate articles